Those are pretty optimistic projections, Ispro. I would think that positive beta site results, FDA approval and the establishment of luminary sites (one already.) are very achievable. But I believe getting anywhere near $3 per share will only happen when Imaging3 gets listed on one of the big boards and it sounds like Dean has plans for that. If all this should come to pass, then .14 per share is an extremely bargain price.